A recent study raises questions about the frequency of doctors’ use of elective heart angiograms, which showed no disease in almost 40 percent of patients. BusinessWeek reports: “Doctors may be sending patients too quickly for elective angiograms to detect heart disease, exposing them to radiation and driving up U.S. health-care costs, a study suggests…

Read The [...] Read more »

Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company’s major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta…

Read The Full Article…Boston Scientific Announces Schedule For ACC 2010 Read more »

An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine…

Read The Full Article…Thyroid Hormone Analogue For Treating High Cholesterol Read more »

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online 11 March in the European Heart Journal [1]…

Read The Full Article…Cholesterol Targets For Heart Patients Not Being Met Read more »

People whose “bad” cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar…

Read The Full Article…Safely Lowers ‘Bad’ Cholesterol In Statin-Treated Patients Read more »

An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine…

Read The Full Article…Thyroid Hormone Analogue For Treating High Cholesterol Read more »

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online 11 March in the European Heart Journal [1]…

Read The Full Article…Cholesterol Targets For Heart Patients Not Being Met Read more »

A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published in the top-ranking scientific periodical The New England Journal of Medicine…

Read The Full Article…New Drug Candidate Reduces Blood [...] Read more »

The Swedish biotech company Karo Bio (Reuters: KARO.ST) announced the publication of results from a clinical phase II trial evaluating the company’s liver selective thyroid hormone receptor agonist eprotirome and its ability to further reduce serum LDL cholesterol levels in statin-treated patients…

Read The Full Article…The New England Journal Of Medicine Publishes Clinical Results On Karo [...] Read more »

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published in the New England Journal of Medicine. “Our study has shown a dramatic reduction in the dangerous fats that cause heart disease, [...] Read more »